These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 5386626)

  • 1. Differential ferrioxamine test in haemochromatosis and liver diseases.
    Barry M; Cartei G; Sherlock S
    Gut; 1969 Sep; 10(9):697-704. PubMed ID: 5386626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The differential ferrioxamine test in the management of idiopathic haemochromatosis.
    Smith PM; Lestas AN; Miller JP; Dymock IW; Pitcher CS; Williams R
    Lancet; 1969 Aug; 2(7617):402-5. PubMed ID: 4184489
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential ferrioxamine test in idiopathic haemochromatosis and transfusional haemosiderosis.
    Fielding J; O'Shaughnessy MC; Brunström GM
    J Clin Pathol; 1966 Mar; 19(2):159-64. PubMed ID: 5909697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of body-iron stores in cirrhosis and haemochromatosis with the differential ferrioxamine test.
    Smith PM; Studley F; Williams R
    Lancet; 1967 Jan; 1(7482):133-6. PubMed ID: 4163312
    [No Abstract]   [Full Text] [Related]  

  • 5. Erythrocyte ferritin content in idiopathic haemochromatosis and alcoholic liver disease with iron overload.
    Van Der Weyden MB; Fong H; Salem HH; Batey RG; Dudley FJ
    Br Med J (Clin Res Ed); 1983 Mar; 286(6367):752-4. PubMed ID: 6402233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current concepts in rational therapy for haemochromatosis.
    Crawford DH; Halliday JW
    Drugs; 1991 Jun; 41(6):875-82. PubMed ID: 1715264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Idiopathic hemochromatosis--diagnosis and therapy].
    Schmidt U; Preu E; Tuschy U; Senf L; Herre K
    Z Gesamte Inn Med; 1984 Apr; 39(8):152-60. PubMed ID: 6730591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of serum ferritin in the management of idiopathic haemochromatosis.
    Batey RG; Hussein S; Sherlock S; Hoffbrand AV
    Scand J Gastroenterol; 1978; 13(8):953-7. PubMed ID: 725519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum increase and liver overexpression of carbohydrate 19.9 antigen in patients with genetic haemochromatosis.
    Deugnier YM; Rabot AF; Guyader D; Moirand R; Turlin B; Boucher E; Lebert P; Brissot P
    Gut; 1994 Aug; 35(8):1107-11. PubMed ID: 7926915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Idiopathic haemochromatosis. I. Clinical, biological and therapeutic aspects (author's transl)].
    Simon M; Bourel M
    Nouv Presse Med; 1979 Mar; 8(11):855-9. PubMed ID: 377216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of diethylenetriamine penta-acetic acid (D.T.P.A.) in the clinical assessment of total body iron stores.
    Powell LW; Thomas MJ
    J Clin Pathol; 1967 Nov; 20(6):896-904. PubMed ID: 5614075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron absorption in normal subjects and patients with idiopathic haemochromatosis: relationship with serum ferritin concentration.
    Walters GO; Jacobs A; Worwood M; Trevett D; Thomson W
    Gut; 1975 Mar; 16(3):188-92. PubMed ID: 804432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cirrhosis with secondary siderosis or primary haemochromatosis.
    Williams R
    Proc R Soc Med; 1967 Dec; 60(12):1255-7. PubMed ID: 6066568
    [No Abstract]   [Full Text] [Related]  

  • 14. Desferrioxamine utilisation for the quantitation of iron excess. Study of 24 patients having idiopathic haemochromatosis.
    Saddi R; Feingold J; Degrese CH; Fagard R
    Biomedicine; 1978; 28(1):41-7. PubMed ID: 667275
    [No Abstract]   [Full Text] [Related]  

  • 15. Deferoxamine-chelatable iron in hemochromatosis and other disorders of iron overload.
    Baldus WP; Fairbanks VF; Dickson ER; Baggenstoss AH
    Mayo Clin Proc; 1978 Mar; 53(3):157-65. PubMed ID: 628226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venesection therapy in idiopathic haemochromatosis. An analysis of 40 treated and 18 untreated patients.
    Williams R; Smith PM; Spicer EJ; Barry M; Sherlock S
    Q J Med; 1969 Jan; 38(149):1-16. PubMed ID: 4303815
    [No Abstract]   [Full Text] [Related]  

  • 17. Iron overload in haemochromatosis.
    Dymock IW; Miller JP; Godfrey BE; Williams R
    Proc R Soc Med; 1970 Dec; 63(12):1227-30. PubMed ID: 5490768
    [No Abstract]   [Full Text] [Related]  

  • 18. Long term results of venesection therapy in idiopathic haemochromatosis.
    Bomford A; Williams R
    Q J Med; 1976 Oct; 45(180):611-23. PubMed ID: 188063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemochromatosis].
    Phlippen R
    Munch Med Wochenschr; 1972 Feb; 114(5):147-9. PubMed ID: 5066916
    [No Abstract]   [Full Text] [Related]  

  • 20. Lysosomal disruption in the pathogenesis of hepatic damage in primary and secondary haemochromatosis.
    Peters TJ; Selden C; Seymour CA
    Ciba Found Symp; 1976 Dec 7-9; (51):317-29. PubMed ID: 1052036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.